Wells Fargo & Company Celldex Therapeutics, Inc. Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 33,378 shares of CLDX stock, worth $734,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,378

Previous 32,498 2.71%

Holding current value

$734,316

Previous $821,000 26.31%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$18.15 - $27.6 $15,971 - $24,288	880 Added 2.71%	33,378 $605,000
Q4 2024 Feb 12, 2025	BUY	$23.31 - $32.4 $235,127 - $326,818	10,087 Added 45.01%	32,498 $821,000
Q3 2024 Nov 13, 2024	SELL	$32.06 - $44.56 $10,419 - $14,482	-325 Reduced 1.43%	22,411 $761,000
Q2 2024 Aug 13, 2024	BUY	$32.76 - $42.56 $36,723 - $47,709	1,121 Added 5.19%	22,736 $841,000
Q1 2024 May 10, 2024	BUY	$35.22 - $51.88 $241,644 - $355,948	6,861 Added 46.5%	21,615 $907,000
Q4 2023 Feb 09, 2024	SELL	$22.61 - $40.65 $612,165 - $1.1 Million	-27,075 Reduced 64.73%	14,754 $585,000
Q3 2023 Nov 13, 2023	SELL	$25.45 - $37.46 $312,322 - $459,709	-12,272 Reduced 22.68%	41,829 $1.15 Million
Q2 2023 Aug 15, 2023	BUY	$30.29 - $38.28 $621,429 - $785,352	20,516 Added 61.09%	54,101 $1.84 Million
Q1 2023 May 12, 2023	BUY	$34.78 - $47.43 $1.13 Million - $1.54 Million	32,538 Added 3107.74%	33,585 $1.21 Million
Q4 2022 Feb 13, 2023	SELL	$27.78 - $45.38 $42,142 - $68,841	-1,517 Reduced 59.17%	1,047 $46,000
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $5,538 - $9,167	-244 Reduced 8.69%	2,564 $73,000
Q2 2022 Aug 12, 2022	SELL	$20.5 - $37.33 $615,471 - $1.12 Million	-30,023 Reduced 91.45%	2,808 $75,000
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $383,670 - $545,800	-13,881 Reduced 29.72%	32,831 $1.12 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $946,483 - $1.49 Million	26,527 Added 131.42%	46,712 $1.81 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $580,042 - $1.12 Million	20,036 Added 13446.98%	20,185 $1.09 Million
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $414 - $707	-20 Reduced 11.83%	149 $5,000
Q1 2021 May 13, 2021	SELL	$16.19 - $29.91 $798,620 - $1.48 Million	-49,328 Reduced 99.66%	169 $3,000
Q4 2020 Feb 09, 2021	BUY	$14.99 - $22.75 $736,233 - $1.12 Million	49,115 Added 12857.33%	49,497 $866,000
Q3 2020 Nov 05, 2020	BUY	$9.65 - $15.19 $1,264 - $1,989	131 Added 52.19%	382 $6,000
Q2 2020 Aug 13, 2020	SELL	$1.61 - $13.41 $127 - $1,059	-79 Reduced 23.94%	251 $3,000
Q1 2020 May 14, 2020	BUY	$1.55 - $3.07 $511 - $1,013	330 New	330 $0

Others Institutions Holding CLDX

# of Institutions

188

Shares Held

69.3M

Call Options Held

220K

Put Options Held

310K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.03B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Celldex Therapeutics, Inc. Transaction History